With more than 2,000 clinicians certified in more than 80 medical specialties and subspecialties, UT Physicians provides multispecialty care for the entire family.
There has been an error in displaying this message. Please contact the site administrator.
Miguel A. Escobar, MD, is a fellowship-trained hematologist with expertise in bleeding and clotting disorders. He’s the director of the Gulf States Hemophilia and Thrombophilia Center — Texas Medical Center. He oversees 1000 patients with bleeding and clotting disorders, and his center participates in most clinical trials for hemophilia, including gene therapy.
He’s also a tenured professor of hematology in the Department of Internal Medicine and the Department of Pediatrics at McGovern Medical School at UTHealth Houston and at The University of Texas MD Anderson Cancer Center.
Escobar is a member of the World Federation of Hemophilia Board of Directors and chair of the Scientific and Standardization Subcommittee on FVIII, Factor IX, and Rare Coagulation Disorders for the International Society on Thrombosis and Haemostasis.
Escobar is the director of the outpatient and inpatient anticoagulation services and co-director of the clinical research unit at McGovern Medical School. In a research career spanning 20 years, he has participated in numerous multicenter clinical studies nationally and internationally. He partners extensively with academia and industry in running collaborative studies and as a clinical investigator. Escobar has received many teaching awards for his dedication to education and is recognized internationally as an expert in his field.
Dean’s Teaching Excellence Award, McGovern Medical School
2021 Physician of the Year Award from the National Hemophilia Foundation, USA.
The American Society of Hematology
The International Society of Thrombosis and Haemostasis
All patient experience ratings and comments are submitted by actual patients and are received and validated by a leading independent survey company, NRC Health.
